Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 6—June 2003
Dispatch

Anthroponotic Cutaneous Leishmaniasis, Kabul, Afghanistan

Richard Reithinger*†Comments to Author , Mohammad Mohsen†, Khoksar Aadil†, Majeed Sidiqi†, Panna Erasmus†, and Paul G. Coleman*
Author affiliations: *London School of Hygiene & Tropical Medicine, London, U.K.; †HealthNet International, Peshawar, Pakistan

Main Article

Figure

A, the average probability of having a lesion at different levels of lesion prevalence recorded among other members of the same household (open circles) and the unadjusted fit (solid line) from the logistic regression. B, the average probability of having a scar at different levels of scar prevalence recorded in other members of the same household (open circles) and the unadjusted fit (solid line) from the logistic regression. C, average probability of having a scar at different levels of scar p

Figure. A, the average probability of having a lesion at different levels of lesion prevalence recorded among other members of the same household (open circles) and the unadjusted fit (solid line) from the logistic regression. B, the average probability of having a scar at different levels of scar prevalence recorded in other members of the same household (open circles) and the unadjusted fit (solid line) from the logistic regression. C, average probability of having a scar at different levels of scar prevalence in nearest neighbor households (open circles) and the unadjusted fit (solid line) from the logistic regression. D, force of infection, λ, can be estimated from the age-prevalence data, where the proportion, P, of persons with ACL at age a (where a is age at last birthday plus 0.5 years) is given by P(a) = 1-exp(-λa) (6). If one assumes that age-independent transmission started 12 years earlier (1), λ was estimated by maximum likelihood by using the observed age-prevalence data for children <12 y of age.

Main Article

References
  1. Ashford  R, Kohestany  K, Karimzad  M. Cutaneous leishmaniasis in Kabul: observations on a prolonged epidemic. Ann Trop Med Parasitol. 1992;86:361–71.PubMedGoogle Scholar
  2. Killick-Kendrick  R, Killick-Kendrick  M, Tang  Y. Anthroponotic cutaneous leishmaniasis in Kabul: the high susceptibility of Phlebotomus sergenti to Leishmania tropica. Trans R Soc Trop Med Hyg. 1995;89:477. DOIPubMedGoogle Scholar
  3. Griffiths  WDA. Old World cutaneous leishmaniasis. In: Peters W, Killick-Kendrick R, editors. The leishmaniases in biology and medicine. London: Academic Press; 1987. p. 617–43.
  4. World Health Organization. Cutaneous leishmaniasis, Afghanistan. Wkly Epidemiol Rec. 2002;29:246.PubMedGoogle Scholar
  5. Rowland  M, Munir  A, Durrani  N, Noyes  H, Reyburn  H. An outbreak of cutaneous leishmaniasis in an Afghan refugee settlement in north-west Pakistan. Trans R Soc Trop Med Hyg. 1999;93:133–6. DOIPubMedGoogle Scholar
  6. Williams  B, Dye  CM. Maximum-likelihood for parasitologists. Parasitol Today. 1994;10:489–93. DOIPubMedGoogle Scholar
  7. Trouiller  P, Torreele  E, Olliaro  P, White  N, Foster  S, Wirth  D, Drugs for neglected diseases: a failure of the market and a public health failure? Trop Med Int Health. 2001;6:945–51. DOIPubMedGoogle Scholar
  8. Boelaert  M, Le Ray  D, Van Der Stuyft  P. How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis. Trop Med Int Health. 2002;7:955–9. DOIPubMedGoogle Scholar

Main Article

Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external